Patents Assigned to Neogenix Oncology, Inc.
  • COLON AND PANCREAS CANCER PEPTIDOMIMETICS
    Publication number: 20130247232
    Abstract: The invention relates to a peptidomimetic of an NPC-1 epitope on the MUC5AC protein which is differentially expressed in pancreatic and colorectal cancer, and diagnostic and therapeutic usages. Further, antibodies that selectively bind the NPC-1 epitope peptidomimetics and may be used in diagnostic and therapeutic methods.
    Type: Application
    Filed: September 23, 2011
    Publication date: September 19, 2013
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventor: Xue-Ping Wang
  • MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER
    Publication number: 20120034227
    Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
    Type: Application
    Filed: January 21, 2011
    Publication date: February 9, 2012
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: Myron Arlen, Kwong Tsang
  • MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER
    Publication number: 20110165599
    Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
    Type: Application
    Filed: January 21, 2011
    Publication date: July 7, 2011
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: Myron ARLEN, Kwong TSANG
  • RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
    Publication number: 20110158902
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Application
    Filed: January 24, 2011
    Publication date: June 30, 2011
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: Myron ARLEN, J. Andrew Bristol, Ariel C. Hollinshead, Kwong Y. Tsang
  • RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
    Publication number: 20110129416
    Abstract: The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
    Type: Application
    Filed: January 24, 2011
    Publication date: June 2, 2011
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: J. Andrew BRISTOL, Judith A. Kantor
  • RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
    Publication number: 20110076761
    Abstract: The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
    Type: Application
    Filed: August 19, 2010
    Publication date: March 31, 2011
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: J. Andrew BRISTOL, Judith A. KANTOR
  • RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
    Publication number: 20100310559
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 9, 2010
    Applicant: Neogenix Oncology, Inc.
    Inventors: Myron Arlen, J. Andrew Bristol, Ariel C. Hollinshead, Kwong Y. Tsang
  • Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    Patent number: 7829678
    Abstract: The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: November 9, 2010
    Assignee: Neogenix Oncology, Inc.
    Inventors: J. Andrew Bristol, Judith A. Kantor
  • Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    Patent number: 7763720
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: July 27, 2010
    Assignee: Neogenix Oncology, Inc.
    Inventors: Myron Arlen, J. Andrew Bristol, Ariel C. Hollnshead, Kwong Y. Tsang
  • RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
    Publication number: 20090162931
    Abstract: The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
    Type: Application
    Filed: November 7, 2008
    Publication date: June 25, 2009
    Applicant: NEOGENIX ONCOLOGY, INC.
    Inventors: J. Andrew BRISTOL, Judith A. KANTOR
  • Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    Publication number: 20080227965
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Application
    Filed: December 17, 2007
    Publication date: September 18, 2008
    Applicant: Neogenix Oncology, Inc.
    Inventors: Myron Arlen, J. Andrew Bristol, Ariel C. Hollinshead, Kwong Y. Tsang
  • Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    Patent number: 7314622
    Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: January 1, 2008
    Assignee: Neogenix Oncology, Inc.
    Inventors: Myron Arlen, J. Andrew Bristol, Ariel C. Hollinshead, Kwong Y. Tsang